Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy
Elina Khatoon, Parama Dey, Aviral Kumar, et al.
Life Sciences (2022) Vol. 306, pp. 120827-120827
Closed Access | Times Cited: 19

Showing 19 citing articles:

Tumour-infiltrating lymphocytes: from prognosis to treatment selection
Koen Brummel, Anneke L. Eerkens, Marco de Bruyn, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 3, pp. 451-458
Open Access | Times Cited: 114
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
Kun Pang, Zhenduo Shi, Liuya Wei, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100907-100907
Closed Access | Times Cited: 108
Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions
Qiang Yu, Jiajun Ding, Shisen Li, et al.
Cancer Letters (2024) Vol. 590, pp. 216856-216856
Closed Access | Times Cited: 8
Autophagy in Cancer Immunotherapy
Yuhe Lei, Enxin Zhang, Liangliang Bai, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2996-2996
Open Access | Times Cited: 30
Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics
Aviral Kumar, Sosmitha Girisa, Mohammed S. Alqahtani, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 810-810
Open Access | Times Cited: 19
Inflammation and Immune Escape in Ovarian Cancer: Pathways and Therapeutic Opportunities
Chunyan Liu, Qinan Yin, Zhaoying Wu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 895-909
Open Access
Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome
Jing‐Fang Wang, Wenrui Zhu, Xia Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells
Xin Shen, Xuli Jin, Shuang Fang, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 9
CAR-T cells for cancer immunotherapy
Yangyang Xie, Xiaotong Li, Jingyi Wu, et al.
Chinese Chemical Letters (2023) Vol. 34, Iss. 9, pp. 108202-108202
Closed Access | Times Cited: 8
Therapeutic potential of tocotrienols as chemosensitizers in cancer therapy
Bethsebie Lalduhsaki Sailo, Suravi Chauhan, Mangala Hegde, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 2
Recent advances in cancer therapy using PARP inhibitors
Simran Kaur, Dinesh Kumar Chellappan, Alaa A. A. Aljabali, et al.
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 11
New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer—A Systematic Review
Cornelia Bachmann
Cancers (2023) Vol. 15, Iss. 22, pp. 5356-5356
Open Access | Times Cited: 5
Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics
Anjana Sajeev, Bandari BharathwajChetty, Mukesh Kumar Manickasamy, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Human organs-on-a-chip for cancer modeling
Mangala Hegde, Sosmitha Girisa, Choudhary Harsha
Elsevier eBooks (2024), pp. 549-581
Closed Access
Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer
Xue Zhang, Wenjie Yin, Aili Zhang, et al.
Journal of Obstetrics and Gynaecology (2024) Vol. 44, Iss. 1
Open Access
Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications
Meshack Bida, Thabiso Victor Miya, Rodney Hull, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Regulating the regulators: long non-coding RNAs as autophagic controllers in chronic disease management
Aviral Kumar, Kenneth Chun-Hong Yap, Bandari BharathwajChetty, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access
Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment
Qiuying Quan, Lingchuan Guo, Lili Huang, et al.
Medicine (2023) Vol. 102, Iss. 48, pp. e36323-e36323
Open Access | Times Cited: 1
Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy
Amina I. Makandar, Mannat Jain, Eiji Yuba, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2049-2049
Open Access | Times Cited: 2
Page 1

Scroll to top